The Latest Cardiac and Vascular News
MOUNTAIN VIEW, Calif., Feb. 10, 2022 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the appointment of Patricia Baran as Senior Vice President, Healthcare Americas. In this role, Baran will report to Vincent Balsamo, Executive Vice President of Worldwide Sales. Baran will lead the Employer, Payor, and Health System business segments […]
New look and logo to position Radcliffe as a multimedia knowledge network and global market leader for the cardiovascular community. LONDON, England, Feb. 10, 2022 (GLOBE NEWSWIRE) — Radcliffe Group has unveiled a new brand identity across its core business, including its three specialist channels: Radcliffe Cardiology, Radcliffe Vascular, and Radcliffe Medical Education. The […]
Toronto & Vienna, Feb. 10, 2022 (GLOBE NEWSWIRE) — February 10, 2022 – FUJIFILM VisualSonics, a global provider of ultra-high-frequency (UHF) ultrasound imaging systems, and PIUR IMAGING, the European leader in tomographic ultrasound imaging, have partnered to bring UHF, three-dimensional (3D) ultrasound imaging technology to clinicians and researchers. This technological advancement supports […]
MALVERN, PA & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that the Phase 2b trial of bentracimab, which was conducted in healthy, older volunteers 50-80 years old, has been accepted for presentation in […]
WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment for secondary prevention in patients with a non-cardioembolic ischemic stroke. Asundexian is an oral inhibitor of Factor Eleven (FXIa) 1 that Bayer is developing […]
Financial Results and Highlights Recent Period Activity − Achieved Fourth Quarter and Full Year 2021 Global Net Product Revenues of $199 Million and $662 Million, Respectively, Representing 83% Annual Growth Compared to 2020 – − Reported Positive 18-Month Results from HELIOS-A Phase 3 Study of Vutrisiran in hATTR Amyloidosis Patients with […]
On behalf of Johnson & Johnson, we have exciting organizational news to share, which will continue to help advance our mission to enable a healthier future for patients. Celine Martin has recently been appointed to the new role of Company Group Chairman, Cardiovascular & Specialty Solutions (CSS) Group. In this […]
Front Line Medical Technologies Article for CardiacVascular News Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as an adjunct for Patients Arriving in Cardiac Arrest to the Emergency Room Out-of-hospital cardiac arrest (OHCA) continues to be overwhelmingly fatal despite improvements in Advanced Cardiovascular Life Support (ACLS) protocols and increasing access […]
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) refinements and three new high-value tools. These updates come in […]
Perfuze develops catheter-based technology for treating acute ischemic stroke Financing was led by new investors LSP and Seroba Life Sciences and joined by new investor SV Health Investors and existing investors GALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic […]
